Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,238.00
(
0.70%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
101.94
(
0.73%
)
Bitcoin
77,500.00
(
-0.99%
)
News Focus
News Focus
Post# of 257442
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: biomaven0 post# 130958

Sunday, 11/13/2011 3:52:43 PM

Sunday, November 13, 2011 3:52:43 PM

Post# of 257442
Efficacy is only part of equation, safety and long term data are more important to get market share. Tasigna and Sprycel are good examples. They are against non-generic Gleevec. CML is a very crowded with highly effective drugs on the market already.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today